Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ABM-1310
i
Other names:
ABM-1310, ABM1310, ABM 1310
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
ABM Therap
Drug class:
BRAF V600E inhibitor
Related drugs:
‹
vemurafenib (212)
FORE-8394 (20)
CB-006-3 (1)
RX208 (0)
vemurafenib (212)
FORE-8394 (20)
CB-006-3 (1)
RX208 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF V600E
Glioblastoma
BRAF V600E
Glioblastoma
ABM-1310
Sensitive: B - Late Trials
ABM-1310
Sensitive
:
B
ABM-1310
Sensitive: B - Late Trials
ABM-1310
Sensitive
:
B
BRAF V600
Solid Tumor
BRAF V600
Solid Tumor
ABM-1310
Sensitive: C2 – Inclusion Criteria
ABM-1310
Sensitive
:
C2
ABM-1310
Sensitive: C2 – Inclusion Criteria
ABM-1310
Sensitive
:
C2
BRAF V600E
Colorectal Cancer
BRAF V600E
Colorectal Cancer
ABM-1310
Sensitive: D – Preclinical
ABM-1310
Sensitive
:
D
ABM-1310
Sensitive: D – Preclinical
ABM-1310
Sensitive
:
D
BRAF V600E
Melanoma
BRAF V600E
Melanoma
ABM-1310
Sensitive: D – Preclinical
ABM-1310
Sensitive
:
D
ABM-1310
Sensitive: D – Preclinical
ABM-1310
Sensitive
:
D
BRAF V600
Colon Cancer
BRAF V600
Colon Cancer
ABM-1310
Sensitive: D – Preclinical
ABM-1310
Sensitive
:
D
ABM-1310
Sensitive: D – Preclinical
ABM-1310
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login